Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?

Heinz Wiendl, Dennis Bourdette, Olga Ciccarelli

Research output: Contribution to journalEditorial

6 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1098-1100
Number of pages3
JournalNeurology
Volume89
Issue number11
DOIs
StatePublished - Sep 1 2017
Externally publishedYes

Fingerprint

Multiple Sclerosis
alemtuzumab

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis? / Wiendl, Heinz; Bourdette, Dennis; Ciccarelli, Olga.

In: Neurology, Vol. 89, No. 11, 01.09.2017, p. 1098-1100.

Research output: Contribution to journalEditorial

Wiendl, Heinz ; Bourdette, Dennis ; Ciccarelli, Olga. / Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?. In: Neurology. 2017 ; Vol. 89, No. 11. pp. 1098-1100.
@article{56ac09826caf4e2d910a30556ebf07cd,
title = "Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?",
author = "Heinz Wiendl and Dennis Bourdette and Olga Ciccarelli",
year = "2017",
month = "9",
day = "1",
doi = "10.1212/WNL.0000000000004381",
language = "English (US)",
volume = "89",
pages = "1098--1100",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?

AU - Wiendl, Heinz

AU - Bourdette, Dennis

AU - Ciccarelli, Olga

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85033578773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033578773&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000004381

DO - 10.1212/WNL.0000000000004381

M3 - Editorial

AN - SCOPUS:85033578773

VL - 89

SP - 1098

EP - 1100

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 11

ER -